Electrocore, Inc. revenue
Electrocore, Inc.'s revenue was $32.0m in fiscal 2025, up 27.2% on the year before. Since fiscal 2017 ($811,457) it has grown at a compound 58.3% a year. Over the last twelve months it was $37.0m.
Revenue history
| Fiscal year | 2017Dec 2017 | 2018Dec 2018 | 2019Dec 2019 | 2020Dec 2020 | 2021Dec 2021 | 2022Dec 2022 | 2023Dec 2023 | 2024Dec 2024 | 2025Dec 2025 | LTMJun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1 | 1 | 2 | 3 | 5 | 9 | 16 | 25 | 32 | 37 |
| Growth on the year before | — | +22.4% | +140.7% | +46.3% | +55.9% | +57.6% | +86.6% | +57.1% | +27.2% | — |
| Gross profit | 0 | 0 | 1 | 2 | 4 | 7 | 13 | 21 | 28 | 32 |
| Gross margin | 36.1% | 41.7% | 51.6% | 50.3% | 74.6% | 81.2% | 82.5% | 85.0% | 86.8% | 87.1% |
Revenue against peers
| Company | Revenue | Growth | 3-year growth a year |
|---|---|---|---|
| Electrocore, Inc. | $37.0m | 33.5% | 50.4% |
| Cytosorbents Corp | $37.2m | 3.1% | 0.8% |
| Utah Medical Products Inc | $36.1m | -7.0% | -11.4% |
| Retractable Technologies Inc | $33.9m | -11.2% | -14.7% |
| Orchestra Biomed Holdings, Inc. | $32.0m | 986.1% | 94.5% |
| Myomo, Inc. | $43.3m | 6.1% | 35.4% |
Compare with peers
- Cytosorbents Corp revenue
- Utah Medical Products Inc revenue
- Retractable Technologies Inc revenue
- Orchestra Biomed Holdings, Inc. revenue
- Myomo, Inc. revenue
Head to head: CTSO vs ECORECOR vs UTMDECOR vs RVP
More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies